These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

318 related articles for article (PubMed ID: 33918043)

  • 21. Prognostic value of early [18F]fluoroethyltyrosine positron emission tomography after radiochemotherapy in glioblastoma multiforme.
    Piroth MD; Pinkawa M; Holy R; Klotz J; Nussen S; Stoffels G; Coenen HH; Kaiser HJ; Langen KJ; Eble MJ
    Int J Radiat Oncol Biol Phys; 2011 May; 80(1):176-84. PubMed ID: 20646863
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Advanced magnetic resonance imaging in glioblastoma: a review.
    Shukla G; Alexander GS; Bakas S; Nikam R; Talekar K; Palmer JD; Shi W
    Chin Clin Oncol; 2017 Aug; 6(4):40. PubMed ID: 28841802
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [What's next in glioblastoma treatment: Tumor-targeted or immune-targeted therapies?].
    Schernberg A; Marabelle A; Massard C; Armand JP; Dumont S; Deutsch E; Dhermain F
    Bull Cancer; 2016 May; 103(5):484-98. PubMed ID: 27032303
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunotherapy and Response Assessment in Malignant Glioma: Neuro-oncology Perspective.
    Bagley SJ; Desai AS; Nasrallah MP; O'Rourke DM
    Top Magn Reson Imaging; 2020 Apr; 29(2):95-102. PubMed ID: 32271286
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Advanced MRI assessment to predict benefit of anti-programmed cell death 1 protein immunotherapy response in patients with recurrent glioblastoma.
    Qin L; Li X; Stroiney A; Qu J; Helgager J; Reardon DA; Young GS
    Neuroradiology; 2017 Feb; 59(2):135-145. PubMed ID: 28070598
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Current and Future Imaging Methods for Evaluating Response to Immunotherapy in Neuro-Oncology.
    Kasten BB; Udayakumar N; Leavenworth JW; Wu AM; Lapi SE; McConathy JE; Sorace AG; Bag AK; Markert JM; Warram JM
    Theranostics; 2019; 9(17):5085-5104. PubMed ID: 31410203
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Editorial Comment: MRI and PET for Immunotherapy Response Assessment in Glioblastoma Multiforme.
    Prattipati V
    AJR Am J Roentgenol; 2022 Apr; 218(4):597. PubMed ID: 34319166
    [No Abstract]   [Full Text] [Related]  

  • 28. Treatment-related changes in glioblastoma: a review on the controversies in response assessment criteria and the concepts of true progression, pseudoprogression, pseudoresponse and radionecrosis.
    Delgado-López PD; Riñones-Mena E; Corrales-García EM
    Clin Transl Oncol; 2018 Aug; 20(8):939-953. PubMed ID: 29218626
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Laser interstitial thermal therapy for newly diagnosed and recurrent glioblastoma.
    Thomas JG; Rao G; Kew Y; Prabhu SS
    Neurosurg Focus; 2016 Oct; 41(4):E12. PubMed ID: 27690657
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A comprehensive profile of recurrent glioblastoma.
    Campos B; Olsen LR; Urup T; Poulsen HS
    Oncogene; 2016 Nov; 35(45):5819-5825. PubMed ID: 27041580
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Imaging Glioblastoma Posttreatment: Progression, Pseudoprogression, Pseudoresponse, Radiation Necrosis.
    Strauss SB; Meng A; Ebani EJ; Chiang GC
    Radiol Clin North Am; 2019 Nov; 57(6):1199-1216. PubMed ID: 31582045
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Multiparametric MRI for early identification of therapeutic response in recurrent glioblastoma treated with immune checkpoint inhibitors.
    Song J; Kadaba P; Kravitz A; Hormigo A; Friedman J; Belani P; Hadjipanayis C; Ellingson BM; Nael K
    Neuro Oncol; 2020 Nov; 22(11):1658-1666. PubMed ID: 32193547
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Response Assessment in Neuro-Oncology criteria, contrast enhancement and perfusion MRI for assessing progression in glioblastoma.
    Tensaouti F; Khalifa J; Lusque A; Plas B; Lotterie JA; Berry I; Laprie A; Cohen-Jonathan Moyal E; Lubrano V
    Neuroradiology; 2017 Oct; 59(10):1013-1020. PubMed ID: 28842741
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Current challenges in designing GBM trials for immunotherapy.
    Weathers SP; Gilbert MR
    J Neurooncol; 2015 Jul; 123(3):331-7. PubMed ID: 25577401
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differentiating Between Primary Central Nervous System Lymphomas and Glioblastomas: Combined Use of Perfusion-Weighted and Diffusion-Weighted Magnetic Resonance Imaging.
    Makino K; Hirai T; Nakamura H; Kuroda JI; Shinojima N; Uetani H; Kitajima M; Yano S
    World Neurosurg; 2018 Apr; 112():e1-e6. PubMed ID: 29104150
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dynamic study of methionine positron emission tomography in patients with glioblastoma with oligodendroglial components.
    Yano H; Ohe N; Nakayama N; Nomura Y; Miwa K; Shinoda J; Iwama T
    Brain Tumor Pathol; 2015 Oct; 32(4):253-60. PubMed ID: 25812514
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impact of imaging measurements on response assessment in glioblastoma clinical trials.
    Reardon DA; Ballman KV; Buckner JC; Chang SM; Ellingson BM
    Neuro Oncol; 2014 Oct; 16 Suppl 7(Suppl 7):vii24-35. PubMed ID: 25313236
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Combination of IVIM-DWI and 3D-ASL for differentiating true progression from pseudoprogression of Glioblastoma multiforme after concurrent chemoradiotherapy: study protocol of a prospective diagnostic trial.
    Liu ZC; Yan LF; Hu YC; Sun YZ; Tian Q; Nan HY; Yu Y; Sun Q; Wang W; Cui GB
    BMC Med Imaging; 2017 Feb; 17(1):10. PubMed ID: 28143434
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Novel approaches and mechanisms of immunotherapy for glioblastoma.
    Hegde M; Bielamowicz KJ; Ahmed N
    Discov Med; 2014 Mar; 17(93):145-54. PubMed ID: 24641957
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Applying protein-based amide proton transfer MR imaging to distinguish solitary brain metastases from glioblastoma.
    Yu H; Lou H; Zou T; Wang X; Jiang S; Huang Z; Du Y; Jiang C; Ma L; Zhu J; He W; Rui Q; Zhou J; Wen Z
    Eur Radiol; 2017 Nov; 27(11):4516-4524. PubMed ID: 28534162
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.